Immunotoxicological effects of Agent Orange exposure to the Vietnam war Korean veterans

Industrial Health

Volumn 41, Issue 3, 2003, Pages 158-166

  Kim, Hyoung Ah ^a   Kim, Eun Mi ^b   Park, Yeong Chul ^b   Yu, Ji Yeon ^c   Hong, Seung Kwon ^c   Jeon, Seong Hoon ^d   Park, Kui Lea ^e   Hur, Sook Jin ^e   Heo, Yong ^b  

^a The Catholic University of Korea   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Seoul National University   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Korea Food and Drug Administration   (South Korea)

Author keywords

Agent Orange; Autoantibodies; Cytokines; Imunoglobulins; RBC; Vietnam War Veterans

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,4,5 TRICHLOROPHENOXYACETIC ACID; GAMMA INTERFERON; HEMOGLOBIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADULT; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ERYTHROCYTE; HEMATOCRIT; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; IMMUNOTOXICITY; INTERFERON PRODUCTION; LEUKOCYTE; MAJOR CLINICAL STUDY; OCCUPATIONAL EXPOSURE; SOLDIER; T LYMPHOCYTE;

ANIMALIA;

EID: 0042170265     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.41.158     Document Type: Article

References (41)

1. Ministry of Patriots & Veterans Affairs and Yonsei Medical Center (2001) Epidemiologic study on Agent Orange-induced health hazards, Korea.
2. Ministry of Patriots & Veterans Affairs (2003) Agent Orange Registry, Korea.
3. Ministry of Health & Welfare (1996) Epidemiological results on Agent Orange-associated health risk to the Vietnam War Korean Veterans, Korea.
4. Pohjanvitra R, Tuomisto J (1994) Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol Rev 46, 483-549.
5. Heo Y, Saxon A, Hankinson O (2001) Effect of diesel exhaust particles and their components on the allergen-specific IgE and IgG1 response in mice. Toxicology 159, 143-58.
6. Suh J, Jeon YJ, Kim HM, Kang JS, Kaminski NE, Yang K-H (2002) Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activate B cells. Toxicol Appl Pharmacol 181, 116-23.
7. + T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol Appl Pharmacol 185, 146-52.
8. Camacho IA, Hassuneh MR, Nagarkatti M, Nagarkatti PS (2001) Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 165, 51-63.
9. + T cells in adoptively transferred mice. Toxicol Sci 56, 340-50.
10. Baccarelli A, Mocarelli P, Patterson DG, Bonzini M, Pesatori AC, Caporaso N, Landi MT (2002) Immunologic effects of dioxin: new results from Seveso and comparison with other studies. Env Health Perspect 110, 1169-73.
11. Michalek JE, Ketchum NS, Check IJ (1999) Serum dioxin and immunologic responses in veterans of Operation Ranch Hand. Am J Epidemiol 149, 1038-46.
12. Kim H-A, Heo Y, Oh S-Y, Lee K-J, Lawrence DA (1999) Altered serum cytokine and immunoglobulin levels in the workers exposed to antimony. Human & Exp Toxicol 18, 607-13.
13. Braun A, Wiebe P, Pfeufer A, Geßner R, Renz H (1999) Differential modulation of human immunoglobulin isotype production by the neuropeptides substances P, NKA, and NKB. J Neuroimmunol 97, 43-50.
14. Silvy A, Lagresle C, Bella C, Defrance T (1996) The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent. Eur J Immunol 26, 517-24.
15. Wyngaarden JB, Smith LH, Bennett JC (1988) Cecil textbook of medicine. 19th ed., 2370-80, W.B. Saunders Company, Philadelphia.
16. Jefferis R, Kumararatne DS (1990) Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 81, 357-67.
17. Cookson (2002) Genetics and genomics of asthma and allergic diseases. Immunol Rev 190, 195-206.
18. Kimber I, Selgrade MK (1998) T lymphocyte subpopulations in immunotoxicology. 1st ed., 157-294, John Wiley & Sons, New York.
19. Heo Y, Lee WT, Lawrence DA (1998) Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes. Toxicol Sci 43, 172-85.
20. + T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 27, 1128-35.
21. Tan TM (1989) Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44, 93-151.
22. Vaile JH, Dyke L, Kherani R, Johnston C, Higgins T, Russell AS (2000) Is high titre ANA specific for connective tissue disease? Clin Exp Rheumatol 18, 433-8.
23. Bertazzi PA, Consonni D, Bachetti S, Rubagoti M, Baccarelli A, Zoccheti C (2001) Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol 153, 1031-44.
24. Neubert R, Maskow L, Triebig G, Broding HC, Jacob-Muller U, Helge H, Neubert D (2000) Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system: 3. plasma immunoglobulins and cytokines of workers with quantified moderately-increased body burden. Life Sci 66, 2123-42.
25. Nel AE, Diaz-Sanchez D, Ng D, Hiura T, Saxon A (1998) Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J. Allergy Clin Immunol 102 (4 pt 1), 539-54.
26. Peden DB (2000) Development of atopy and asthma; candidate environmental influences and important periods of exposure. Environ Health Perspect 108 (Suppl 3), 475-82.
27. Takenaka H, Zhang K, Diaz-Sanchez D, Tsien A, Saxon A (1995) Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol 95, 103-15.
28. Halperin W, Vogt R, Sweeney MH, Shopp G, Fingerhut M, Petersen M (1998) Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 55, 742-9.
29. Ernst M, Flesch-Janys D, Morgenstern I, Manz A (1998) Immune cell functions in industrial workers after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: dissociation of antigen-specific T-cell responses in cultures of diluted whole blood and of isolated peripheral blood mononuclear cells. Environ Health Perspect 106 (Suppl 2), 701-5.
30. Michalek JE, Longnecker MP, Burton JE (2001) relation of serum 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) level to hematological examination results in veterans of Operation Ranch Hand. Arch Environ Health 56, 396-405.
31. Losana G, Rigamonti L, Borghi I, Assenzio B, Ariotti S, Jouanguy E, Altare F, Fomi G, Casanova J-L, Novelli F (2002) Requirement for both IL-12 and IFN-γ production by human T cells. Eur J Immunol 32, 693-700.
32. Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17, 593-623.
33. Ho JW, Liang RH, Srivastava G (1999) Preferential type-1 cytokine gene expression in peripheral T-cell lymphomas. Hematol Oncol 17, 117-29.
34. Kostense S, Sun WH, Cottey R, Taylor SF, Harmeling S, Zander D, Small PA, Bender BS (1998) Interleukin-12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice. Antiviral Res 38, 117-30.
35. Ono SJ (2000) Molecular genetics of allergic diseases. Annu Rev Immunol 18, 347-66.
36. Krieger J, Heo Y, Lawrence DA (1998) Oxidative stress and heavy metal modification of T lymphocyte subsets. In: T-Lymphocyte Subpopulations in Immunotoxicology. eds. by Kimber I, Selgrade MK, 103-19, John Wiley & Sons, New York.
37. Kiecolt-Glaser JK (1999) Stress, personal relationships, and immune function: health implications. Brain Behav Immun 13, 61-72.
38. Marshall GD, Agarwal SK, Lloyd C, Cohen L, Henninger EM, Morris GJ (1998) Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav Immun 12, 297-307.
39. Elenkov IJ, Chrousos GP (1999) Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metabol 10, 359-68.
40. Vedhara KV, Cox NKM, Wilcock GK, Perks P, Hunt M, Anderson S, Lightman SL (1999) Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353, 627-31.
41. Glaser R, Sheridan J, Malarkey WB, MacCallum RG, Kiecolt-Glaser JK (2000) Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom Med 62, 804-7.